News

Nasus Pharma Welcomes Eyal Rubin as New CFO to Enhance Growth

Nasus Pharma Welcomes Eyal Rubin as New CFO to Enhance Growth

Nasus Pharma Welcomes Eyal Rubin as CFO

Nasus Pharma Ltd. (NYSE:NSRX), a company dedicated to nurturing innovative intranasal medical treatments, has appointed Eyal Rubin as its Executive Vice President and Chief Financial Officer. With over 20 years of experience in the biotechnology and pharmaceutical industries, Mr. Rubin is poised to strengthen the company's financial leadership.

Expertise in Financial Leadership

In his new role, Eyal Rubin will lead Nasus Pharma's financial operations, managing everything from corporate finance to investor relations. His extensive expertise aims to advance the company's pipeline of intranasal therapeutics, which are at the heart of their urgent medical care innovations.

Comments from Leadership

CEO Dan Teleman expressed enthusiasm about Rubin's joining the company. He noted, "We believe his robust financial knowledge and deep understanding of capital markets will significantly benefit us during this growth phase." Telman believes the timing aligns perfectly with Nasus Pharma's aspirations to enhance its product offerings.

Valuable Experience Brought to the Team

Udi Gilboa, the Executive Chairman of Nasus Pharma, conveyed confidence in Rubin's capabilities, stating, "His background in both emerging biotech and established pharmaceutical firms will be an asset as we build our operational strength." The leadership team anticipates that Mr. Rubin’s insights will facilitate the strategic execution of their clinical programs.

Prior Accomplishments of Eyal Rubin

Before joining Nasus Pharma, Eyal Rubin served as CFO and Senior Vice President at Protalix BioTherapeutics, Inc. There, he honed his skills in financial strategy and capital market communications. His previous roles also include financial leadership at BrainStorm Cell Therapeutics, Inc., and strategic treasury management at Teva Pharmaceutical Industries Ltd.

Innovations in Drug Delivery

Nasus Pharma focuses on revolutionary intranasal drug delivery technologies designed to address acute medical conditions with rapid response solutions. Their product candidate, NS002, represents a needle-free alternative for patients experiencing anaphylaxis, showcasing the potential of the company's innovations.

The Future of Nasus Pharma

Mr. Rubin himself expressed enthusiasm about contributing to Nasus Pharma: "I am thrilled to join at such a transformative time. I believe that our intranasal delivery systems represent a breakthrough in addressing significant unmet medical needs. I look forward to supporting our goals for long-term growth and success."

About Nasus Pharma

Nasus Pharma is dedicated to advancing healthcare through clinical-stage products that provide effective solutions for urgent medical conditions. Their proprietary powder-based intranasal technology is specifically crafted for effective drug delivery while ensuring patient ease-of-use. For more details, please visit www.nasuspharma.com or follow them on Twitter and LinkedIn.

Frequently Asked Questions

What is Nasus Pharma's core focus?

Nasus Pharma specializes in developing innovative intranasal products for emergency medical conditions.

Who has been appointed as the new CFO?

Eyal Rubin has been appointed as the Executive Vice President and Chief Financial Officer of Nasus Pharma.

What is the significance of Mr. Rubin's experience?

His extensive financial background in biotechnology and pharmaceuticals is expected to greatly benefit Nasus Pharma as it seeks to expand its operations.

What is the company’s product candidate NS002?

NS002 is an intranasal powder Epinephrine designed as a needle-free alternative for treating anaphylaxis.

How can I learn more about Nasus Pharma?

You can find additional information on their official website at www.nasuspharma.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Alyssa Bunch: Big Moves in Tennessee Real Estate

Updated Category News Views 40

Navigating the Tennessee Real Estate Maze If you're talking about where the real estate action happens in Tennessee, you'd better mention Alyssa Bunch, the Vanderbilt-educated dynamo who turns the unforsale into the must-buy. Most of the deals she orchestrates are invisible to the public eye until they're all but written in ink and ready to reshape landscapes—or, more...

Continue Reading
Protalix Posts Strong Gains, Eyes Future Milestones

Updated Category News Views 58

Big Numbers and Bigger Ambitions Protalix BioTherapeutics has come out strong in their third quarter of 2026, showcasing some staggering numbers and laying out ambitious plans for the future. They've managed to pump their revenues up to a cool $75.6 million year-to-date, a leap from $43.6 million in the same period last year. You don't need a crystal ball to see them...

Continue Reading
Trucker Path Enhances App with CB Radio Feature

Updated Category News Views 59

Reviving a Classic for Modern Safety In an age ruled by high-speed internet and relentless notifications, you'd think a technology as old as CB radios would've been left in the dust, but here we are! Trucker Path just rolled out a revamped CB Radio feature in their app, and man, it's fast becoming a game-changer for these highway warriors. From Nostalgia to Necessity...

Continue Reading
Coastal Construction Revamps South Florida's Equipment Game

Updated Category News Views 69

Revolutionizing Equipment Acquisition in South Florida Looks like the sun's shining a bit differently on South Florida's contractors. Coastal Construction Equipment, LLC just announced their big debut as a new player on the Cat Compact™ scene, turning the tides for those in the construction industry. With a plan that's as big as a bulldozer, they'll be breaking ground,...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 113

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
CeQur Revolutionizes Insulin Delivery with Wearable Patch

Updated Category News Views 61

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Continue Reading
McKinley Irvin Adds Veteran Willa Staats to Legal Team

Updated Category News Views 0

New Talent Joins a Leading Family Law Firm Some folks think of family law as just another branch of the legal world, but let's be real—it's where emotions run high and stakes can catch you off guard like a sudden market downturn. So, when McKinley Irvin, one of the Pacific Northwest’s top family law outfits, brings someone new aboard, that’s worth putting under the...

Continue Reading
VIAVI Innovates with 5G Digital Twins in UK Transport

Updated Category News Views 127

VIAVI Rides the Rails with Digital Twins The latest buzzword flashing across the tech scene? Digital twins. But VIAVI Solutions Inc. (NASDAQ: VIAV) isn’t just riding the trend; it's driving it forward. Partnering up with ORBIT, this heavy-hitter aims to redesign the digital blueprint of Blackpool's transportation system. And no, this ain't just pretty talk for...

Continue Reading
BD Sets Stage for Investor Day in December 2026

Updated Category News Views 35

BD's Investor Day: A Peek into the Future Say what you will about investor meets, but BD (Becton, Dickinson and Company) throwing its shindig on December 10, 2026, could be a highlight on the calendar if you're eyeing the medical technology sector. Scheduled in New York, this event is gearing up to be a canvas for BD's higher-ups to sketch out their roadmap. If you’re...

Continue Reading
VT Markets Unites Trading and Drama in New Finale

Updated Category News Views 105

Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...

Continue Reading

Top 5 Most Recently Viewed Articles

Brookfield Asset Management Secures $750 Million Note Offering

Updated Category News Views 114

Brookfield Asset Management's Latest Offering of Notes Brookfield Asset Management Ltd. (“BAM”) (NYSE: BAM, TSX: BAM) has recently made headlines with its announcement regarding a public offering of $750 million in senior notes due 2055, featuring an attractive interest rate of 6.077% per annum. This strategic move showcases BAM's commitment to fortifying its...

Continue Reading
Xinjiang's Growth: A Bright Future Awaits Under New Strategies

Updated Category News Views 374

Xinjiang's Economic Evolution: A Time of Prosperity Xinjiang is currently witnessing an era of unparalleled growth and development. As highlighted in a recent white paper issued by the Information Office of the State Council, this region has embarked on a transformative journey. The focus on lawful governance, cultural integration, and economic fortification promises a...

Continue Reading
Understanding Short Selling Dynamics at Pinnacle Financial Partners

Updated Category News Views 125

Pinnacle Financial Partners' Recent Short Interest Trends Pinnacle Finl Partners's (NYSE: PNFP) short percent of float has seen a decline of 6.22% since its last report. The company announced that it now has 1.50 million shares sold short, constituting 1.96% of the total regular shares available for trading. Given the average trading volume, it would take traders roughly...

Continue Reading
MY DR NOW Expands in Gilbert Amid Doctor Shortage

Updated Category News Views 19

Addressing A Deficit in Primary Care In a world where finding a doctor feels harder than hitting the lottery, MY DR NOW just tossed a lifeline to Gilbert, Arizona. It's a town growing faster than weeds after a rainstorm. With its fifth clinic debuting, MY DR NOW is taking a swing at a problem gripping not just Gilbert, but the whole state: a critical shortage of primary...

Continue Reading
Legal Action Alert for Starbucks Corporation Shareholders

Updated Category News Views 98

Overview of the Class Action Lawsuit Against Starbucks Levi & Korsinsky, LLP has initiated a class action lawsuit for investors in Starbucks Corporation, trading under NASDAQ: SBUX. This legal action aims to recover losses experienced by shareholders due to alleged securities fraud. Understanding the specifics of this case and its implications for investors is crucial....

Continue Reading